Creator bought Nvidia during a significant sell-off, indicating a contrarian buying strategy.
Source Post
Medtronic Stock Analysis: I Ran The Numbers
Dividend Compounders with CheeseMay 17, 2026
The creator analyzes Medtronic (MDT), the world's largest medical device company. The analysis covers its business segments, recent divestiture of its diabetes unit, acquisition of CathWorks, and the impact of slowing growth in China. The creator believes Medtronic's diversification into software and the aging global population present opportunities.
Linked Mentions
Tickers discussed in this post
Creator bought AMD during a significant sell-off, indicating a contrarian buying strategy.
Creator bought into United Health during fear, implying a contrarian approach.
Medtronic is potentially tied with Stryker for second place.
Medtronic is preferred over Boston Scientific.
Medtronic is preferred over Edwards Lifesciences.
Abbott Laboratories is the top pick due to diversified revenue streams and essential products.
Altria is cited as an example of a mature company where a higher dividend payout ratio is acceptable.
Cal-Maine Foods is mentioned as an example of a company with a very strong balance sheet (no debt).
Oracle's debt situation is noted as an example of significant, unexplained debt increases.
Medtronic (MDT) is a large medical device company with a diversified business and potential growth from an aging population, but faces headwinds from China's economy.
Linked Signals
Tracked calls opened from this post
ABT
buy opened May 17, 2026
+2.96%